Breaking News Instant updates and real-time market news.

TENB

Tenable Holdings

$29.51 /

-0.14 (-0.47%)

08:05
06/11/20
06/11
08:05
06/11/20
08:05

Tenable Holdings price target raised to $35 from $30 at Monness Crespi

Monness Crespi analyst Ryan Flanagan raised the firm's price target on Tenable Holdings to $35 from $30 and keeps a Buy rating on the shares as he thinks that the shift to remote working underscores the critical nature of identifying vulnerabilities and assessing risk exposure. Though "no one is immune from the deteriorating spending environment," Flanagan thinks security is somewhat less discretionary, he added.

TENB Tenable Holdings
$29.51 /

-0.14 (-0.47%)

04/15/20 Monness Crespi
Monness Crespi starts Tenable Holdings at Buy with $30 price target
04/15/20 Monness Crespi
Tenable Holdings initiated with a Buy at Monness Crespi
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
03/24/20 Goldman Sachs
Tenable Holdings initiated with a Buy at Goldman Sachs

TODAY'S FREE FLY STORIES

General news
Treasury Market Outlook: stocks are surging amid news of a possible successful coronavirus vaccine » 07:50
07/15/20
07/15
07:50
07/15/20
07:50

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Theratechnologies says liquidity position sufficient for the foreseeable future » 07:49
07/15/20
07/15
07:49
07/15/20
07:49
THTX

Theratechnologies

$2.17 /

-0.04 (-1.81%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

Hot Stocks
Theratechnologies to submit IND application for TH1902 trial before year-end » 07:48
07/15/20
07/15
07:48
07/15/20
07:48
THTX

Theratechnologies

$2.17 /

-0.04 (-1.81%)

Theratechnologies is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

Initiation
Wex initiated with a Positive at Susquehanna » 07:47
07/15/20
07/15
07:47
07/15/20
07:47
WEX

Wex

$152.62 /

-0.47 (-0.31%)

Susquehanna analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WEX Wex
$152.62 /

-0.47 (-0.31%)

WEX Wex
$152.62 /

-0.47 (-0.31%)

07/14/20 Goldman Sachs
Wex initiated with a Neutral at Goldman Sachs
05/28/20 Deutsche Bank
Wex price target raised to $172 from $150 at Deutsche Bank
05/07/20 BTIG
Wex price target lowered to $190 from $255 at BTIG
05/04/20 Baird
Wex price target raised to $152 from $132 at Baird
WEX Wex
$152.62 /

-0.47 (-0.31%)

WEX Wex
$152.62 /

-0.47 (-0.31%)

Hot Stocks
Theratechnologies to initiate Phase 3 study of tesamorelin around year-end » 07:47
07/15/20
07/15
07:47
07/15/20
07:47
THTX

Theratechnologies

$2.17 /

-0.04 (-1.81%)

Following its initial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

Hot Stocks
Theratechnologies to file supplemental BLA for F8 formulation in early 2022 » 07:46
07/15/20
07/15
07:46
07/15/20
07:46
THTX

Theratechnologies

$2.17 /

-0.04 (-1.81%)

On July 7, 2020, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

Hot Stocks
Theratechnologies transitions EGRIFTA patients to EGRIFTA SV formulation » 07:45
07/15/20
07/15
07:45
07/15/20
07:45
THTX

Theratechnologies

$2.17 /

-0.04 (-1.81%)

The Company implemented a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

Upgrade
Xylem upgraded to Buy water business resilience at Rosenblatt » 07:45
07/15/20
07/15
07:45
07/15/20
07:45
XYL

Xylem

$73.38 /

+6.06 (+9.00%)

Rosenblatt analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XYL Xylem
$73.38 /

+6.06 (+9.00%)

XYL Xylem
$73.38 /

+6.06 (+9.00%)

07/14/20 Rosenblatt
Xylem upgraded to Buy from Neutral at Rosenblatt
06/04/20 Rosenblatt
Xylem price target raised to $70 from $63 at Rosenblatt
05/15/20 Vertical Research
Xylem upgraded to Hold from Sell at Vertical Research
05/07/20 Cowen
Xylem price target lowered to $50 from $65 at Cowen
XYL Xylem
$73.38 /

+6.06 (+9.00%)

XYL Xylem
$73.38 /

+6.06 (+9.00%)

Hot Stocks
Theratechnologies says Trogarzo IV slow push study to be complete in 2H20 » 07:44
07/15/20
07/15
07:44
07/15/20
07:44
THTX

Theratechnologies

$2.17 /

-0.04 (-1.81%)

A study evaluating an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

Initiation
FleetCor initiated with a Positive at Susquehanna » 07:44
07/15/20
07/15
07:44
07/15/20
07:44
FLT

FleetCor

$248.88 /

+0.56 (+0.23%)

Susquehanna analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLT FleetCor
$248.88 /

+0.56 (+0.23%)

FLT FleetCor
$248.88 /

+0.56 (+0.23%)

07:13 Today Credit Suisse
FleetCor price target raised to $255 from $250 at Credit Suisse
07/14/20 Goldman Sachs
FleetCor initiated with a Buy at Goldman Sachs
07/09/20 Jefferies
Jefferies upgrades 'increasingly attractive' FleetCor to Buy from Hold
07/09/20 Jefferies
FleetCor upgraded to Buy from Hold at Jefferies
FLT FleetCor
$248.88 /

+0.56 (+0.23%)

FLT FleetCor
$248.88 /

+0.56 (+0.23%)

FLT FleetCor
$248.88 /

+0.56 (+0.23%)

Hot Stocks
Theratechnologies says supply chain remains unaffected 'at this time' » 07:43
07/15/20
07/15
07:43
07/15/20
07:43
THTX

Theratechnologies

$2.17 /

-0.04 (-1.81%)

At this time,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

Earnings
Theratechnologies reports Q2 EPS (8c) vs. (4c) last year » 07:43
07/15/20
07/15
07:43
07/15/20
07:43
THTX

Theratechnologies

$2.17 /

-0.04 (-1.81%)

Reports Q2 revenue $17.2M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

12/11/19 Mackie
Theratechnologies upgraded to Buy from Hold at Mackie
12/02/19 Canaccord
Theratechnologies initiated with a Buy at Canaccord
THTX Theratechnologies
$2.17 /

-0.04 (-1.81%)

Recommendations
NN Group price target raised to EUR 36 from EUR 32.50 at Deutsche Bank » 07:41
07/15/20
07/15
07:41
07/15/20
07:41
NNGRY

NN Group

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NNGRY NN Group
$0.00 /

+ (+0.00%)

NNGRY NN Group
$0.00 /

+ (+0.00%)

06/30/20 JPMorgan
NN Group price target raised to EUR 39.20 from EUR 35 at JPMorgan
06/26/20 Morgan Stanley
NN Group price target raised to EUR 35.40 from EUR 34.80 at Morgan Stanley
06/25/20 UBS
NN Group price target raised to EUR 32.30 from EUR 29.60 at UBS
06/23/20 Berenberg
NN Group initiated with a Hold at Berenberg
Hot Stocks
Qiwi completes sale of SOVEST project » 07:40
07/15/20
07/15
07:40
07/15/20
07:40
QIWI

Qiwi

$17.98 /

-0.2 (-1.10%)

QIWI announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QIWI Qiwi
$17.98 /

-0.2 (-1.10%)

QIWI Qiwi
$17.98 /

-0.2 (-1.10%)

06/18/20 JPMorgan
Qiwi price target raised to $25 from $19 at JPMorgan
05/21/20 JPMorgan
Qiwi price target raised to $19 from $18 at JPMorgan
03/11/20 JPMorgan
Qiwi price target lowered to $25 from $28 at JPMorgan
11/25/19
Fly Intel: Top five analyst initiations
QIWI Qiwi
$17.98 /

-0.2 (-1.10%)

QIWI Qiwi
$17.98 /

-0.2 (-1.10%)

Recommendations
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank » 07:39
07/15/20
07/15
07:39
07/15/20
07:39
BPMC

Blueprint Medicines

$79.68 /

+2.86 (+3.72%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$79.68 /

+2.86 (+3.72%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$79.68 /

+2.86 (+3.72%)

06:30 Today H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Piper Sandler
Blueprint Medicines' deal with Roche neutral on model, says Piper Sandler
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
RHHBY Roche
$0.00 /

+ (+0.00%)

06:30 Today H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Piper Sandler
Blueprint Medicines' deal with Roche neutral on model, says Piper Sandler
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
BPMC Blueprint Medicines
$79.68 /

+2.86 (+3.72%)

RHHBY Roche
$0.00 /

+ (+0.00%)

  • 23
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$79.68 /

+2.86 (+3.72%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Cytokinetics provides update on cardiovascular pipeline, commercial strategies » 07:38
07/15/20
07/15
07:38
07/15/20
07:38
CYTK

Cytokinetics

$27.88 /

+3.73 (+15.45%)

Cytokinetics management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$27.88 /

+3.73 (+15.45%)

CYTK Cytokinetics
$27.88 /

+3.73 (+15.45%)

07:17 Today Cantor Fitzgerald
Cytokinetics price target raised to $41 from $29 at Cantor Fitzgerald
06:38 Today JMP Securities
Cytokinetics price target raised to $29 from $23 at JMP Securities
07/14/20 H.C. Wainwright
Cytokinetics price target raised to $38 from $35 at H.C. Wainwright
07/14/20 Piper Sandler
Cytokinetics price target raised to $33 from $28 at Piper Sandler
CYTK Cytokinetics
$27.88 /

+3.73 (+15.45%)

CYTK Cytokinetics
$27.88 /

+3.73 (+15.45%)

Recommendations
Boston Beer price target raised to $540 from $481 at Deutsche Bank » 07:38
07/15/20
07/15
07:38
07/15/20
07:38
SAM

Boston Beer

$622.27 /

+32.44 (+5.50%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

07/14/20 Evercore ISI
Boston Beer initiated with an Outperform at Evercore ISI
06/10/20 Guggenheim
Boston Beer price target raised to $609 from $549 at Guggenheim
06/08/20 RBC Capital
Boston Beer price target raised to $575 from $427 at RBC Capital
06/01/20 Cowen
Boston Beer price target raised to $650 from $570 at Cowen
SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

Hot Stocks
Goldman Sachs sees 2020 global GDP down 3.4%, 2021 GDP up 6.2% » 07:37
07/15/20
07/15
07:37
07/15/20
07:37
GS

Goldman Sachs

$214.29 /

+5.36 (+2.57%)

Goldman previously…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

07/08/20 Seaport Global
Goldman Sachs initiated with a Buy at Seaport Global
06/26/20 Morgan Stanley
Morgan Stanley sees dividend cuts at Wells Fargo, Capital One after stress tests
06/05/20 Wells Fargo
Goldman Sachs price target raised to $255 from $230 at Wells Fargo
06/04/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

Initiation
Church & Dwight initiated with a Buy at Argus » 07:36
07/15/20
07/15
07:36
07/15/20
07:36
CHD

Church & Dwight

$84.46 /

+2.33 (+2.84%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

07:25 Today Argus
Church & Dwight initiated with a Buy at Argus
06/24/20 Oppenheimer
Church & Dwight price target raised to $88 from $83 at Oppenheimer
06/18/20
Fly Intel: Top five analyst upgrades
06/18/20 Credit Suisse
Credit Suisse upgrades Church & Dwight, says 'built to withstand' recession
CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

Earnings
OpGen reports Q2 preliminary revenue $1.2M, one est. $1.2M » 07:36
07/15/20
07/15
07:36
07/15/20
07:36
OPGN

OpGen

$1.98 /

-0.085 (-4.12%)

OpGen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPGN OpGen
$1.98 /

-0.085 (-4.12%)

OPGN OpGen
$1.98 /

-0.085 (-4.12%)

06/09/20 Alliance Global Partners
Alliance Global Partners sees OpGen preliminary data as positive
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
OPGN OpGen
$1.98 /

-0.085 (-4.12%)

Hot Stocks
Novocure, Merck enter clinical trial collaboration to develop NSCLC treatment » 07:35
07/15/20
07/15
07:35
07/15/20
07:35
NVCR

Novocure

$58.12 /

+0.04 (+0.07%)

, MRK

Merck

$78.26 /

+0.88 (+1.14%)

Novocure (NVCR) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$58.12 /

+0.04 (+0.07%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

NVCR Novocure
$58.12 /

+0.04 (+0.07%)

07/10/20 Piper Sandler
Novocure glioblastoma opportunity in China underappreciated, says Piper Sandler
07/06/20 Mizuho
Novocure has large growth opportunity in China, says Mizuho
05/20/20 Piper Sandler
Novocure remains top idea in oncology equipment at Piper Sandler
05/13/20 Piper Sandler
Piper says Novocure opens up largest GBM market with China approval
MRK Merck
$78.26 /

+0.88 (+1.14%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
NVCR Novocure
$58.12 /

+0.04 (+0.07%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

NVCR Novocure
$58.12 /

+0.04 (+0.07%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

Hot Stocks
Moleculin Biotech partners with Sterling Pharma to produce COVID-19 candidate » 07:34
07/15/20
07/15
07:34
07/15/20
07:34
MBRX

Moleculin Biotech

$0.79 /

-0.0168 (-2.10%)

Moleculin Biotech has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MBRX Moleculin Biotech
$0.79 /

-0.0168 (-2.10%)

MBRX Moleculin Biotech
$0.79 /

-0.0168 (-2.10%)

04/08/20 Roth Capital
Moleculin can expedite COVID candidate amid less restrictions, says Roth Capital
10/17/19 Oppenheimer
Moleculin Biotech initiated with an Outperform at Oppenheimer
Downgrade
Marvell downgraded to Equal Weight after recent rally at Wells Fargo » 07:32
07/15/20
07/15
07:32
07/15/20
07:32
MRVL

Marvell

$37.21 /

+0.53 (+1.44%)

Wells Fargo analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$37.21 /

+0.53 (+1.44%)

MRVL Marvell
$37.21 /

+0.53 (+1.44%)

06:01 Today Wells Fargo
Marvell downgraded to Equal Weight from Overweight at Wells Fargo
07/07/20 Needham
Marvell price target raised to $39 from $34 at Needham
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
05/29/20 Susquehanna
Marvell delivered results beyond expectations, says Susquehanna
MRVL Marvell
$37.21 /

+0.53 (+1.44%)

MRVL Marvell
$37.21 /

+0.53 (+1.44%)

MRVL Marvell
$37.21 /

+0.53 (+1.44%)

MRVL Marvell
$37.21 /

+0.53 (+1.44%)

Earnings
Organogenesis sees Q2 revenue $68M-$68.6M, consensus $48.25M » 07:32
07/15/20
07/15
07:32
07/15/20
07:32
ORGO

Organogenesis

$3.25 /

-0.09 (-2.69%)

Net revenue is based…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORGO Organogenesis
$3.25 /

-0.09 (-2.69%)

ORGO Organogenesis
$3.25 /

-0.09 (-2.69%)

03/06/20 Credit Suisse
Organogenesis price target lowered to $8 from $10 at Credit Suisse
01/10/20 SVB Leerink
Organogenesis initiated with an Outperform at SVB Leerink
08/26/19 Credit Suisse
Organogenesis reinstated with an Outperform at Credit Suisse
ORGO Organogenesis
$3.25 /

-0.09 (-2.69%)

  • 22
    Nov
Downgrade
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA » 07:30
07/15/20
07/15
07:30
07/15/20
07:30
VRCA

Verrica Pharmaceuticals

/

+

BofA analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
/

+

VRCA Verrica Pharmaceuticals
/

+

06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
03/24/20 Needham
Verrica Pharmaceuticals initiated with a Buy at Needham
VRCA Verrica Pharmaceuticals
/

+

VRCA Verrica Pharmaceuticals
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.